BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 2018
View Archived Issues
MedImmune initiates phase I study of MEDI-6570
Read More
89Bio launches to develop drug for NASH
Read More
France becomes first country to market baclofen preparation to reduce alcohol consumption
Read More
Boehringer Ingelheim initiates phase I study of BI-730460
Read More
Uniparental mice give insights into ESC imprinting
Read More
Dual ICOS/CD28 antagonist demonstrates efficacy in models of autoimmune disease
Read More
Single locus near SIM1 gene significantly associated with risk of erectile dysfunction
Read More
OT-1096, a novel immunoactivating molecule that shows efficacy in xenograft models of TNBC
Read More
Phase I U.S. data presented for KN-035 in patients with advanced solid tumors
Read More
Pfizer and Novartis collaborate to study NASH therapy combinations
Read More
ASP-5094 safe and well tolerated in patients with rheumatoid arthritis on methotrexate
Read More
Griffithsin intravaginal gel well tolerated in first-in-human trial
Read More
Opthea reports promising 12-week data from phase Ib study of OPT-302 in DME
Read More
Novo Nordisk reports PIONEER 8 topline results with oral semaglutide in type 2 diabetes
Read More
Phase II data presented for SEL-212 in symptomatic gout patients
Read More
Novartis reports year 2 data from brolucizumab phase III trials in wet AMD
Read More
Genentech presents data on faricimab and ranibizumab PDS in wet AMD
Read More
Aduro initiates phase I study of ADU-1604 in metastatic melanoma
Read More
New phase I trial evaluates TAK-981 in metastatic solid tumors or lymphomas
Read More
Qrumpharma develops inhaled agent for nontuberculous mycobacterial infections
Read More
Innovate demonstrates preclinical proof of concept for larazotide in NASH mouse model
Read More
New phase Ib/IIa study explores use of AG-019 for treatment of early-onset type 1 diabetes
Read More
